By detecting the BRAF V600E mutation and CCR6 levels in LCH samples, we initially observed a correlation between the 2, prompting us to investigate the mechanism by which the BRAF mutation contributes to the development of the inflammatory environment in LCH. This evidence concerns the gene CCR6 and Langerhans cell histiocytosis.